Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1418]
News [1460]
Articles [101]
Editorials [24]
Conferences [146]
elearning [1]
Benefits of metronomic chemotherapy and the aims of the Metronomic Global...
Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France
Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative ( Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France )
10 Jul 2014
Drug repurposing as an alternative to costly drugs such as herceptin in breast...
Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India
Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer ( Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India )
10 Jul 2014
Quality of life and cost advantages of metronomics and drug repurposing
Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK
Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )
10 Jul 2014
Diabetes drug, metformin, repurposed for use against several cancers including...
Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy
Diabetes drug, metformin, repurposed for use against several cancers including breast ( Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy )
10 Jul 2014
Betablockers repurposed to treat neuroblastoma
Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia
Betablockers repurposed to treat neuroblastoma ( Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia )
10 Jul 2014
Networking and collaborating across borders in sub-Saharan Africa
Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer...
Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )
26 Jun 2014
Tackling inequality in access to cancer care and information
Prof Mark Lawler - Queen's University Belfast, Belfast, UK
Tackling inequality in access to cancer care and information ( Prof Mark Lawler - Queen's University Belfast, Belfast, UK )
20 Jun 2014
Personalised medicine in Europe needs to be accessible to all
Prof Mark Lawler - Queen's University Belfast, Belfast, UK
Personalised medicine in Europe needs to be accessible to all ( Prof Mark Lawler - Queen's University Belfast, Belfast, UK )
20 Jun 2014
Lenalidomide versus thalidomide in myeloma
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Lenalidomide versus thalidomide in myeloma ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
19 Jun 2014
Comment: Advances in haematological cancer presented at EHA 2014
Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands
Comment: Advances in haematological cancer presented at EHA 2014 ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )
19 Jun 2014
Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise...
Dr Zafer Başlar - Istanbul University, Istanbul, Turkey
Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety? ( Dr Zafer Başlar - Istanbul University, Istanbul, Turkey )
19 Jun 2014
History and ongoing work of AORTIC
Dr James Holland - Mount Sinai Hospital, New York, USA
History and ongoing work of AORTIC ( Dr James Holland - Mount Sinai Hospital, New York, USA )
5 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation